Phoenix Rising supports the Millions Missing global day of protest
Phoenix Rising is delighted to support the demands being made in the ME/CFS community’s first-ever global day of protest …
Discuss the article on the Forums.

Immunotherapy against EBV: Targeting EBV infected cells using immunotherapy

Discussion in 'Other Health News and Research' started by Ecoclimber, Feb 5, 2014.

  1. Sushi

    Sushi Senior Member Albuquerque

    Messages:
    14,234
    Likes:
    21,347
    Albuquerque
    Dr. Lerner in Michigan is also giving Cidofovir.

    Sushi
     
    NK17 likes this.
  2. Christopher

    Christopher Senior Member

    Messages:
    573
    Likes:
    261
    Pennsylvania
    Confirmation from someone affiliated with CFI of receipt of the study.
     
  3. Cheesus

    Cheesus Senior Member

    Messages:
    1,186
    Likes:
    5,085
    UK
    http://www.medicalnewstoday.com/articles/272326.php
     
    NK17, Ren, Tito and 6 others like this.
  4. Christopher

    Christopher Senior Member

    Messages:
    573
    Likes:
    261
    Pennsylvania
    Now for funding =)
     
  5. Cheesus

    Cheesus Senior Member

    Messages:
    1,186
    Likes:
    5,085
    UK
    I would guess MS has better funding sources than ME, so it hopefully won't be such a marathon. Fingers crossed it could have positive repercussions in ME.
     
    Ren likes this.
  6. Firestormm

    Firestormm

    Messages:
    5,022
    Likes:
    4,826
    Cornwall England
    It does seem very early days. And to be reporting on this in such a way when the study only comprised one patient seems strange. Then again, if the exposure helps bring interest to the team who worked on it - and funding - then large studies with controls if viable in some way - could produce more significant results that night lead to a better understanding of MS and other conditions perhaps.
     
    Valentijn, aimossy, August59 and 2 others like this.
  7. Esther12

    Esther12

    Messages:
    8,449
    Likes:
    28,508
    Yeah - reporting of these sorts of this always seems a bit scary to me, but they're open about the fact that it's just one person.
     
    aimossy and Firestormm like this.
  8. Christopher

    Christopher Senior Member

    Messages:
    573
    Likes:
    261
    Pennsylvania
    "Don't have anywhere near as much fatigue. Nowhere near as much pain."

    Mr. Pender says in the radio interview that the patient's symptoms improved 2 weeks after the injection, and he has remained improved for 1 YEAR after the injection.

    I spoke with Mr. Pender, and the organization MS Queensland is attempting to get a bigger trial going based on his study. The YouTube video below interviews Professor Pender and the patient from the study. According to the video, they need to raise $400,000 for a trial.

    Story from MS Queensland




     
    Last edited: Feb 7, 2014
    NK17, Iquitos, natasa778 and 3 others like this.
  9. perovyscus

    perovyscus

    Messages:
    89
    Likes:
    48
    Partial results from this trial (with vested interest) were disclosed on April 20, 2017, with 3 of 6 patients improving. It is an exceptionally weak trial design given it is Phase I.

    Lot of normal responses of marginal improvement you would see from a state-of-the-art MS drug but here is one that caught my eye:
    • Reduction in fatigue from 60 at baseline to 9 on the fatigue severity scale (FSS) following last study visit (the FSS provides scores in the range from 9-63)
    Full Results in Feb 2018, additional interim in October 2017.
     
    Last edited: Aug 26, 2017
    anni66 and Esther12 like this.

See more popular forum discussions.

Share This Page